BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

HiFiBiO Therapeutics

HiFiBiO Therapeutics logo

Website
http://hifibio.com/
Founded
2013
Clinical Trials
5
Publications
11

Technologies

AI Companies (Drug Discovery)

HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiBiO Therapeutics aspires to benefit patients through open-innovation partnerships with industry and academia.

Microfluidics Single-cell Antibodies


Posts Mentioning This Company

10 Companies Applying AI for Biologics Discovery

Jan. 26, 2024  
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and analyzed in the report The Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D roughly half of more than 300 analyzed …

A Running List Of Covid-19 Treatments In Development (Not Updated)

Oct. 6, 2021  
Disclaimer: This post is not medical advice, it is only for informational purposes. In case of need, consult your doctor at all times to make decisions about your health. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a positive …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

Drug Intelligent Science (DIS™)
Transforming drug discovery and development through single-cell analytics
We are transforming discovery and development by combining our Data Intelligence with our Single-Cell Science to achieve optimal outcomes for target discovery, drug candidate identification, lead optimization, and patient selection.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.